ARWRARROWHEAD PHARMACEUTICALS IN
CUSIP 04280A100 · common stock · Other share classes: 04280AAC4
5 tracked investors held ARROWHEAD PHARMACEUTICALS IN (ARWR) at the end of Q3 2026, worth $175.8M in total. The largest holder was Julian Baker, with 0.5% of its portfolio. Ron Baron opened a new position this quarter.
Holders · Q3 2026
5
New holders
1
Value held
$175.8M
Quarter-end price (est.)
$65.45
Investors holding ARWR · Q3 2026
| Investor | Weight | Shares | Value | Change |
|---|---|---|---|---|
| Julian Baker Baker Bros. Advisors LP | 0.53% | 1,709,053 | $111.9M | REDUCE-14.2% |
| Ken Fisher Fisher Asset Management, LLC | 0.02% | 893,700 | $58.5M | REDUCE-6.7% |
| Adar1 Capital Management ADAR1 Capital Management, LLC | 0.19% | 69,200 | $4.5M | REDUCE-0.9% |
| Joel Greenblatt Gotham Asset Management, LLC | 0.00% | 9,620 | $629.6K | ADD+43.7% |
| Ron Baron BAMCO Inc. (Baron Capital) | 0.00% | 5,000 | $327.3K | NEW |
Sold out this quarter
| Investor | Prior weight | Prior shares | Prior value | Change |
|---|---|---|---|---|
| Polen Capital Management | 0.00% | 6,612 | $538.9K | EXIT |